Cancer is one of the main causes of death worldwide. Current epidemiology studies estimate that approximately 40% of men and women will be diagnosed with this illness at some point in their lives. Unfortunately, it is estimated that the impact of cancer will continue to grow, affecting roughly 23,6 million people by 2030. 

Over 200 different types of cancer are currently identified, breast cancer being the most common among women, representing 29% of all oncological illnesses. It is estimated that 5-10% of the cases of breast cancer are hereditary. The BRCA 1 and 2 genes contain 20-25% of mutations responsible for the development of hereditary breast cancer. What’s more, genes BRACA 1 and 2 are responsible for the majority of cases of hereditary ovarian cancer (approximately 20% of cases of ovarian cancer are hereditary) 

Colorectal cancer represents a tumour more commonly diagnosed in both sexes, affecting men and women in almost the same way. Approximately 5% of cases of colorectal cancer have a well-defined inheritance pattern.

Genetic diagnosis of hereditary cancer is essential for the correct treatment, prognosis and management of the patient. What’s more, it is vitally important for relatives of the patient who could be carriers of the same condition.

Our NGS panels for oncology include genes clinically associated with different oncological illnesses.